文献速递血管炎

血清生物标志物在风湿性多肌痛患者中识别巨细胞动脉炎的诊断准确性

Diagnostic accuracy of serum biomarkers to identify giant cell arteritis in patients with polymyalgia rheumatica.
PubMed 文献 · RMD Open · 2024-08-08

研究纳入45例孤立性风湿性多肌痛(PMR)和29例PMR/巨细胞动脉炎(GCA)重叠患者,在糖皮质激素治疗前检测血清生物标志物。GCA患者sCD141和CXCL9较高,MMP-3和IL-6较低;CXCL9/IL-6比值(切点>32.8,AUC 0.76)和MMP-3/sCD141比值(切点<5.3,AUC 0.79)诊断准确性较高。在亚临床GCA中,sCD141和MMP-3/sCD141比值的AUC分别为0.81和0.77。作者认为联合血清生物标志物有助于在孤立性PMR患者中识别GCA。

要点

  • GCA患者血清sCD141和CXCL9高于孤立性PMR,MMP-3和IL-6低于孤立性PMR。
  • CXCL9/IL-6比值在GCA中升高(切点>32.8,AUC 0.76),MMP-3/sCD141比值降低(切点<5.3,AUC 0.79)。
  • 亚临床GCA中sCD141和MMP-3/sCD141比值AUC分别为0.81和0.77。

核心结论

  • 联合血清生物标志物如CXCL9/IL-6和MMP-3/sCD141有助于在孤立性PMR患者中识别GCA。
  • 可能有助于选择需要进一步检查的PMR患者。

研究设计与样本

  • 纳入45例孤立性PMR和29例PMR/GCA重叠患者,所有患者均在开始糖皮质激素治疗前采集血样。
  • 采用Luminex法检测反映全身炎症(IL-6、CXCL9)、血管重塑(MMP-2、MMP-3、MMP-9)和内皮功能(sCD141、sCD146、ICAM-1、VCAM-1、vWFA2)的血清生物标志物。

主要发现

  • GCA患者血清sCD141(p=0.002)和CXCL9(p=0.002)水平高于孤立性PMR。
  • GCA患者血清MMP-3(p=0.01)和IL-6(p=0.004)水平低于孤立性PMR。
  • sCD141、CXCL9、IL-6和MMP-3单独诊断的AUC均未超过0.7,但联合后诊断准确性提高。
  • CXCL9/IL-6比值在GCA患者中显著升高(p=0.0001;切点>32.8,AUC 0.76)。
  • MMP-3/sCD141比值在GCA患者中显著降低(p<0.0001;切点<5.3,AUC 0.79)。

关键数值与推荐

  • CXCL9/IL-6比值切点>32.8,AUC 0.76。
  • MMP-3/sCD141比值切点<5.3,AUC 0.79。
  • 亚临床GCA中sCD141的AUC为0.81,MMP-3/sCD141比值的AUC为0.77。

临床怎么用

  • 作者认为联合血清生物标志物如CXCL9/IL-6和MMP-3/sCD141可能有助于在孤立性PMR患者中识别GCA。
  • 作者认为可能有助于选择需要进一步检查的PMR患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are frequently overlapping conditions. Unlike in GCA, vascular inflammation is absent in PMR. Therefore, serum biomarkers reflecting vascular remodelling could be used to identify GCA in cases of apparently isolated PMR. MATERIALS AND METHODS: 45 patients with isolated PMR and 29 patients with PMR/GCA overlap were included. Blood samples were collected before starting glucocorticoids for all patients. Serum biomarkers reflecting systemic inflammation (interleukin-6 (IL-6), CXCL9), vascular remodelling (MMP-2, MMP-3, MMP-9) and endothelial function (sCD141, sCD146, ICAM-1, VCAM-1, vWFA2) were measured by Luminex assays. RESULTS: Patients with GCA had higher serum levels of sCD141 (p=0.002) and CXCL9 (p=0.002) than isolated PMR. By contrast, serum levels of MMP-3 (p=0.01) and IL-6 (p=0.004) were lower in GCA than isolated PMR. The area under the curve (AUC) was calculated for sCD141, CXCL9, IL-6 and MMP-3. Separately, none of them were >0.7, but combinations revealed higher diagnostic accuracy. The CXCL9/IL-6 ratio was significantly increased in patients with GCA (p=0.0001; cut-off >32.8, AUC 0.76), while the MMP-3/sCD141 ratio was significantly lower in patients with GCA (p<0.0001; cut-off <5.3, AUC 0.79). In patients with subclinical GCA, which is the most difficult to diagnose, sCD141 and MMP-3/sCD141 ratio demonstrated high diagnostic accuracy with AUC of 0.81 and 0.77, respectively. CONCLUSION: Combined serum biomarkers such as CXCL9/IL-6 and MMP-3/sCD141 could help identify GCA in patients with isolated PMR. It could allow to select patients with PMR in whom complementary examinations are needed.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Ramon A, Greigert H, Goueslard K, et al. Diagnostic accuracy of serum biomarkers to identify giant cell arteritis in patients with polymyalgia rheumatica. RMD Open. 2024. PMID: 39122253. doi:10.1136/rmdopen-2024-004488

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。